La Trobe University's Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI) aims to revolutionize personalized medicine, leveraging AI for faster, cheaper, and more effective drug development and testing on digital twins. ACAMI, launched on September 13, partners with mRNA Victoria and BioNTech, focusing on mRNA therapy, immunotherapies, and cancer vaccines. Initial projects include digital twins for breast cancer, a cancer-detecting biosensor, and colour cell mapping to track cancer spread. The centre aims to enhance Victoria's medical innovation and create AI-enabled medical jobs.